| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Health Care Equipment & Supplies (Health Care sector), NVCR's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 461.4K | $5.14M | - | |
| CEO | 422.6K | $5.62M | - | |
| Dir | 416.7K | $4.65M | - | |
| Other | 328.4K | - | - | |
| Other | 267.2K | $3.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Puri Michal Nath | Chief Human Resources Officer | Sell | 1,387 | $20.02 | $27,772.77 | -1.3% | +0.7% | -29.0% | |
| Feb 27, 2025 | Leupin Nicolas | Chief Medical Officer | Sell | 991 | $20.02 | $19,843.57 | -1.9% | +0.7% | -29.0% | |
| Jan 11, 2025 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 2,160 | $26.81 | $57,906.14 | -6.4% | -39.9% | -48.3% | |
| Nov 2, 2024 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 44 | $16.69 | $734.18 | -1.3% | +51.5% | -24.4% | |
| Nov 1, 2024 | Leonard Frank X76 | EVP, President, Novocure Oncology | Sell | 598 | $15.94 | $9,530.74 | -0.4% | +57.7% | -20.8% | |
| Nov 1, 2024 | Paravasthu Mukund69 | Chief Operating Officer | Sell | 160 | $15.88 | $2,540.42 | -4.4% | +57.7% | -20.8% | |
| Oct 31, 2024 | Puri Michal Nath | Chief Human Resources Officer | Sell | 810 | $15.79 | $12,791.68 | -0.7% | +68.1% | -15.6% | |
| Aug 2, 2024 | Cordova Ashley75 | Chief Financial Officer | Sell | 688 | $20.14 | $13,857.42 | -0.3% | -26.7% | -45.3% | |
| Jun 4, 2024 | Leung Gabriel78 | Director | Sell | 964 | $23.89 | $23,025.24 | -1.2% | -26.6% | -26.7% | |
| Jun 4, 2024 | Scannell Timothy J | Director | Sell | 964 | $23.89 | $23,027.45 | -24.5% | -26.6% | -26.7% |